IL6 and hepatocellular carcinoma: In hepatocellular carcinoma cells, NCTD reversed IL-6-induced epithelial-mesenchymal transition process and inhibited STAT3 phosphorylation like JSI-124, a selective inhibitor of STAT3 [41].